HC Wainwright Maintains Bullish Outlook on Eton Pharmaceuticals Growth Strategy Vickers Insider Trading Report Top Buyers and Sellers for May 27 2026 Hindalco Reports 50 Drop in Q4 Net Profit Due to OneTime Expense of 4171 Crore at Novelis Nvidia Concedes Chinas Advanced AI Chip Market to Huawei CEO Huang States Zscaler ZS Positioned for Turnaround in Expanding ZeroTrust Security Market PutinXi Talks Advance Stalled Power of Siberia 2 Gas Pipeline Amid Iran War Energy Market Turmoil Jade Biosciences Inc JBIO Q1 2026 Earnings Clinicalstage Biotech Misses Consensus as Cash Burn Accelerates TATT Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Drops Over 5 MDB Q1 2026 Earnings EPS Surprises to the Upside but Stock Slides 362 Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress RBLX Q1 2026 Earnings EPS Beats Estimates by 35 Stock Rises TNDM Q1 2026 Earnings BetterThanExpected Losses but Revenue Details Missing SiriusXM Holdings SIRI Holds Steady Near Resistance Amid Cautious Trading SunOpta STKL Holds Steady Near 650 as Shares Trade in a Tight Range General Purpose Acquisition Corp Warrant GPACW Sees Modest Gain Amid Thin Trading Atlantic Union Bankshares AUB Gains 165 Testing Key Resistance Zone Seres Therapeutics MCRB Declines 593 as Selling Pressure Intensifies Global Uncertainty Drags Down Overseas Remittances Under LRS by 2 in FY26 RBI Data Shows Texas Capital Bancshares Series B TCBIO Q1 2026 Earnings EPS Exceeds Estimates as Preferred Stock Holds Steady Amprius Technologies AMPX Rallies 477 as Battery Sector Gains Momentum NRXP Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement STERIS plc STE Q1 2026 Earnings EPS Falls Short Amid Mixed Operating Conditions CATO Q4 2025 Earnings Loss of 055 per Share Amid Challenging Retail Environment Magna International MGA Q1 2026 Earnings EPS Surges Past Estimates Shares Rise MBINN Q1 2026 Earnings EPS Beats Estimates Depositary Shares Rise ELME Q4 2025 Earnings Massive EPS Miss as Company Faces Headwinds Monte Rosa Therapeutics Inc GLUE Q1 2026 Earnings WiderthanExpected Loss Compounds Investor Caution